Abstract
Asthma prevalence in children varies substantially around the world, but the contribution of known risk factors to this international variation is uncertain. The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two studied 8–12 year old children in 30 centres worldwide with parent-completed symptom and risk factor questionnaires and aeroallergen skin prick testing. We used multilevel logistic regression modelling to investigate the effect of adjustment for individual and ecological risk factors on the between-centre variation in prevalence of recent wheeze. Adjustment for single individual-level risk factors changed the centre-level variation from a reduction of up to 8.4% (and 8.5% for atopy) to an increase of up to 6.8%. Modelling the 11 most influential environmental factors among all children simultaneously, the centre-level variation changed little overall (2.4% increase). Modelling only factors that decreased the variance, the 6 most influential factors (synthetic and feather quilt, mother’s smoking, heating stoves, dampness and foam pillows) in combination resulted in a 21% reduction in variance. Ecological (centre-level) risk factors generally explained higher proportions of the variation than did individual risk factors. Single environmental factors and aeroallergen sensitisation measured at the individual (child) level did not explain much of the between-centre variation in wheeze prevalence.
Similar content being viewed by others
References
Weinmayr G, Weiland SK, Björkstén B, Brunekreef B, Büchele G, Cookson WOC, et al. Atopic sensitization and the international variation of asthma symptom prevalence in children. Am J Respir Crit Care Med. 2007;176:565–74.
ISAAC Steering Committee I, Beasley R, Keil U, Von Mutius E, Pearce N. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 1998;351:1225–32.
Weiland SK, Björkstén B, Brunekreef B, Cookson WOC, von Mutius E, Strachan DP. Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods. Eur Respir J. 2004;24:406–12.
von Mutius E, Martinez FD, Fritzsch C, Nicolai T, Roell G, Thiemann HH. Prevalence of asthma and atopy in two areas of West and East Germany. Am J Respir Crit Care Med. 1994;149:358–64.
Wong GWK, Ko FWS, Hui DSC, Fok TF, Carr D, von Mutius E, et al. Factors associated with difference in prevalence of asthma in children from three cities in China: multicentre epidemiological survey. BMJ. 2004;329:486.
ISAAC Steering Comittee. ISAAC Phase Two. http://isaac.auckland.ac.nz/phases/phasetwo/phasetwo.html. Updated 5 Apr 2017. Accessed: 11 Oct 2017.
Weinmayr G, Dreyhaupt J, Jaensch A, Forastiere F, Strachan DP. Multilevel regression modelling to investigate variation in disease prevalence across locations. Int J Epidemiol. 2017;46:336–47.
Bauer DJ. A note on comparing the estimates of models for cluster-correlated or longitudinal data with binary or ordinal outcomes. Psychometrika. 2008;74:97–105.
Richardson DB, Rzehak P, Klenk J, Weiland SK. Analyses of case-control data for additional outcomes. Epidemiology. 2007;18:441–5.
Weinmayr G, Gehring U, Genuneit J, Büchele G, Kleiner A, Siebers R, et al. Dampness and moulds in relation to respiratory and allergic symptoms in children: results from Phase Two of the International Study of Asthma and Allergies in Childhood (ISAAC Phase Two). Clin Exp Allergy. 2013;43:762–74.
Weinmayr G, Forastiere F, Büchele G, Jaensch A, Strachan DP, Nagel G. Overweight/obesity and respiratory and allergic disease in children: International Study of Asthma and Allergies in Childhood (ISAAC) phase two. PLoS ONE. 2014;9:e113996.
García-Marcos L, Castro-Rodríguez JA, Suarez-Varela MM, Garrido JB, Hernandez GG, Gimeno AM, et al. A different pattern of risk factors for atopic and non-atopic wheezing in 9–12-year-old children. Pediatr Allergy Immunol. 2005;16:471–7.
Yemaneberhan H, Bekele Z, Venn A, Lewis S, Parry E, Britton J. Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet. 1997;350:85–90.
Basagaña X, Sunyer J, Kogevinas M, Zock J-P, Duran-Tauleria E, Jarvis D, et al. Socioeconomic status and asthma prevalence in young adults: the European Community Respiratory Health Survey. Am J Epidemiol. 2004;160:178–88.
Heinrich J, Bedada GB, Zock J-P, Chinn S, Norbäck D, Olivieri M, et al. Cat allergen level: its determinants and relationship to specific IgE to cat across European centers. J Allergy Clin Immunol. 2006;118:674–81.
Douwes J, Pearce N. Asthma and the westernization “package”. Int J Epidemiol. 2002;31:1098–102.
Ivert AK, Levander MT, Merlo J. Adolescents’ utilisation of psychiatric care, neighbourhoods and neighbourhood socioeconomic deprivation: a multilevel analysis. PLoS ONE. 2013;8:e81127.
Gupta RS, Zhang X, Sharp LK, Shannon JJ, Weiss KB. The protective effect of community factors on childhood asthma. J Allergy Clin Immunol. 2009;123(1297–1304):e2.
Kogan MD, Singh GK, Dee DL, Belanoff C, Grummer-Strawn LM. Multivariate analysis of state variation in breastfeeding rates in the United States. Am J Public Health. 2008;98:1872–80.
Merlo J, Ostergren PO, Broms K, Bjorck-Linné A, Liedholm H. Survival after initial hospitalisation for heart failure: a multilevel analysis of patients in Swedish acute care hospitals. J Epidemiol Community Health. 2001;55:323–9.
Acknowledgements
We wish to thank all children, parents, teachers, field workers and lab workers for their enormous contributions to this collaborative study.
Funding
This work was supported by the German Research Foundation (DFG) (Grant No. WE 4306/3-1).
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
All investigators in the Phase Two Study Group are listed in the “Appendix”.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Appendix: The ISAAC Phase Two Study group
Appendix: The ISAAC Phase Two Study group
The ISAAC Phase Two Coordinating and Data Centre: S.K. Weiland† (Director), G. Büchele, C. Dentler, A. Jaensch, P. Rzehak, G. Weinmayr (Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany).
The principal investigators: A. Priftanji, A. Shkurti, J. Simenati, E. Grabocka, K. Shyti, S. Agolli, A. Gurakuqi (Tirana, Albania); R.T. Stein, M. Urrutia de Pereira, M.H. Jones, P.M. Pitrez (Uruguaiana, Brazil); P.J. Cooper, M. Chico (Pichincha province, Ecuador); Y.Z. Chen (Beijing, China); N.S Zhong (Guangzhou, China); C.K.W. Lai (National Coordinator), G.W.K. Wong (Hong Kong, China); M-A. Riikjärv, T. Annus (Tallinn, Estonia); I. Annesi-Maesano (Créteil, France); M. Gotua, M. Rukhadze, T. Abramidze, I. Kvachadze, L. Karsanidze, M. Kiladze, N. Dolidze (Tbilisi, Georgia); W. Leupold, U. Keil, E. von Mutius, S.K. Weiland† (Dresden, Germany); E. von Mutius, U. Keil, S.K. Weiland† (Munich, Germany); P. Arthur†, E. Addo-Yobo (Kintampo, Ghana); C. Gratziou (National Coordinator), K. Priftis, A. Papadopoulou, C. Katsardis (Athens, Greece); J. Tsanakas, E. Hatziagorou, F. Kirvassilis (Thessaloniki, Greece); M. Clausen (Reykjavik, Iceland); J.R. Shah, R.S. Mathur, R.P. Khubchandani, S. Mantri (Mumbai, India); F. Forastiere, R. Di Domenicantonio, M. De Sario, S. Sammarro, R. Pistelli, M.G. Serra, G. Corbo, C.A. Perucci (Rome, Italy); V. Svabe, D. Sebre, G. Casno, I. Novikova, L. Bagrade (Riga, Latvia); B. Brunekreef, D. Schram, G. Doekes, P.H.N. Jansen-van Vliet, N.A.H. Janssen, F.J.H. Aarts, G. de Meer (Utrecht, the Netherlands); J. Crane, K. Wickens, D. Barry (Hawkes Bay, New Zealand); W. Nystad, R. Bolle, E. Lund (Tromsø, Norway); J. Batlles Garrido, T. Rubi Ruiz, A. Bonillo Perales, Y. Gonzalez Jiménez, J. Aguirre Rodriguez, J. Momblan de Cabo, A. Losilla Maldonado, M. Daza Torres (Almeria, Spain); L. García-Marcos (National Coordinator), A. Martinez Torres, J.J. Guillén Pérez, A. Piñana López, S. Castejon Robles (Cartagena, Spain); G. García Hernandez, A. Martinez Gimeno, A.L. Moro Rodríguez, C. Luna Paredes, I. Gonzalez Gil (Madrid, Spain); M.M. Morales Suarez-Varela, A. Llopis González, A. Escribano Montaner, M. Tallon Guerola (Valencia, Spain); L. Bråbäck (National Coordinator), M. Kjellman, L. Nilsson, X-M. Mai (Linköping, Sweden); L. Bråbäck, A. Sandin (Östersund, Sweden); Y. Saraçlar, S. Kuyucu, A. Tuncer, C. Saçkesen, V. Sumbulŏglu, P. Geyik, C. Kocabas¸ (Ankara, Turkey); D.P. Strachan, B. Kaur (West Sussex, UK); N. El-Sharif, B. Nemery, F. Barghuthy, S. Abu Huij, M. Qlebo (Ramallah, West Bank); M. van Hage (IgE analyses - Stockholm, Sweden).
The ISAAC Steering Committee: N. Aït-Khaled (Paris, France); H.R. Anderson and D.P. Strachan* (London, UK); C. Flohr* and H. Williams (Nottingham, UK); F. Forastiere* (Rome, Italy); I. Asher, P. Ellwood, A. Stewart and E. Mitchell (Auckland, New Zealand); J. Crane, N. Pearce and R. Beasley (Wellington, New Zealand); B. Björkstén (Stockholm, Sweden); B. Brunekreef* (Utrecht, the Netherlands); S. Foliaki (Nuku’alofa, Kingdom of Tonga); L. García-Marcos (Murcia, Spain); E. von Mutius* (Munich, Germany); U. Keil (Münster, Germany); S.K. Weiland*†, G. Weinmayr* (Ulm, Germany); C.K.W. Lai and G.W.K. Wong (Hong Kong, China); J. Mallol (Santiago, Chile); S. Montefort (Naxxar, Malta); J. Odhiambo† (Nairobi, Kenya); and C. Robertson (Parkville, Australia).
*Also members of the ISAAC Phase Two Steering Group, †Deceased.
Rights and permissions
About this article
Cite this article
Weinmayr, G., Jaensch, A., Ruelius, AK. et al. Can environment or allergy explain international variation in prevalence of wheeze in childhood?. Eur J Epidemiol 34, 509–520 (2019). https://doi.org/10.1007/s10654-018-0463-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-018-0463-z